Rezolute (RZLT) News Today

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

$3.30

+0.06 (+1.85%)

(As of 05:32 PM ET)

Source

Source	Headline
	Rezolute (NASDAQ:RZLT) Given Market Outperform Rating at JMP Securities marketbeat.com - April 18 at 2:21 PM
	Jonestrading Begins Coverage on Rezolute (NASDAQ:RZLT) marketbeat.com - April 18 at 8:35 AM
	Optimistic Buy Rating for Rezolute’s RZ402 Drug Candidate Amid Promising DME Treatment Prospects markets.businessinsider.com - April 18 at 5:30 AM
	Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024? investorplace.com - April 15 at 3:43 PM
	Rezolute Stock (NASDAQ:RZLT), Analyst Ratings, Price Targets, Predictions benzinga.com - April 10 at 4:10 PM
	Rezolute (NASDAQ:RZLT) Receives New Coverage from Analysts at Maxim Group americanbankingnews.com - April 10 at 3:48 AM
	Rezolute (NASDAQ:RZLT) Earns Buy Rating from Analysts at Maxim Group marketbeat.com - April 9 at 8:23 AM
	Insiders Are Buying These 5 Penny Stocks insidermonkey.com - April 4 at 8:51 AM
	Rezolute, Inc. (NASDAQ:RZLT) Short Interest Update marketbeat.com - March 27 at 9:30 PM
	Rezolute Reaches US$75m Market Cap Benefiting Insider Stock Buying finance.yahoo.com - March 27 at 8:51 AM
	3 Stocks Insiders Are Buying That Analysts Love (RZLT) insidertrades.com - March 26 at 12:55 PM
	Rezolute's chief medical officer buys $18.8k in company stock investing.com - March 20 at 5:29 PM
	Daron Evans Buys 20,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) Stock insidertrades.com - March 20 at 7:32 AM
	Rezolute, Inc. (NASDAQ:RZLT) CFO Daron Evans Acquires 20,000 Shares marketbeat.com - March 19 at 10:28 AM
	Brian Kenneth Roberts Acquires 10,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) Stock insidertrades.com - March 19 at 5:40 AM
	Rezolute, Inc. (NASDAQ:RZLT) Insider Brian Kenneth Roberts Buys 10,000 Shares marketbeat.com - March 18 at 1:33 PM
	Insider Buying: Rezolute, Inc. (NASDAQ:RZLT) Director Buys 36,503 Shares of Stock insidertrades.com - March 15 at 11:42 AM
	Insider Buying: Rezolute, Inc. (NASDAQ:RZLT) Director Purchases 36,503 Shares of Stock marketbeat.com - March 14 at 1:36 PM
	Rezolute, Inc. (NASDAQ:RZLT) Sees Significant Growth in Short Interest marketbeat.com - March 13 at 10:52 PM
	Rezolute, Inc. (NASDAQ:RZLT) CFO Acquires $96,500.00 in Stock insidertrades.com - March 11 at 7:22 AM
	Rezolute, Inc. (NASDAQ:RZLT) CFO Buys $96,500.00 in Stock marketbeat.com - March 8 at 4:33 PM
	HC Wainwright Reiterates "Buy" Rating for Rezolute (NASDAQ:RZLT) marketbeat.com - March 7 at 8:20 AM
	Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia (NICTH) globenewswire.com - March 6 at 7:30 AM
	Rezolute, Inc. (NASDAQ:RZLT) Insider Brian Kenneth Roberts Acquires 6,000 Shares marketbeat.com - February 27 at 9:26 AM
	Rezolute Stock (NASDAQ:RZLT) Earnings Dates and Earning Calls benzinga.com - February 22 at 12:13 PM
	Rezolute, Inc. (NASDAQ:RZLT) CFO Daron Evans Buys 41,900 Shares marketbeat.com - February 20 at 9:24 AM
	Rezolute, Inc.: Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update finanznachrichten.de - February 16 at 9:03 AM
	We're Keeping An Eye On Rezolute's (NASDAQ:RZLT) Cash Burn Rate finance.yahoo.com - February 15 at 7:59 AM
	Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update finance.yahoo.com - February 13 at 7:04 PM
	Buy Rating Affirmed for Rezolute’s RZ358 Based on Untapped Market Potential and Therapeutic Efficacy markets.businessinsider.com - February 8 at 8:52 PM
	Rezolute appoints Daron Evans as CFO msn.com - January 24 at 11:20 AM
	Rezolute secures innovation passport designation from U.K. for RZ358 treating hypoglycemia msn.com - January 23 at 2:27 PM
	Rezolute Receives Innovation Passport Designation from the U.K. Innovative Licensing and Access Pathway Steering Group for RZ358 in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism finance.yahoo.com - January 23 at 8:55 AM
	Rezolute Initiates Phase 3 Clinical Study for RZ358 in Congenital Hyperinsulinism finance.yahoo.com - December 14 at 8:25 AM
	Rezolute Completes Enrollment of its Phase 2 Study in Diabetic Macular Edema (“DME”) finance.yahoo.com - December 13 at 9:36 AM
	Rezolute (RZLT) Price Target Increased by 5.77% to 8.42 msn.com - November 28 at 10:59 PM
	Rezolute, Inc.: Rezolute Reports First Quarter Fiscal 2024 Results finanznachrichten.de - November 24 at 8:27 AM
	Rezolute’s Promising Drug Pipeline and Market Position Validate Buy Rating: An Analysis of RZ358 and RZ402 Potential markets.businessinsider.com - November 18 at 12:18 AM
	Rezolute to Participate in BTIG’s 3rd Annual Ophthalmology Day finance.yahoo.com - November 17 at 9:17 AM
	Rezolute GAAP EPS of -$0.28 in-line msn.com - November 14 at 9:36 AM
	Rezolute Reports First Quarter Fiscal 2024 Results finance.yahoo.com - November 13 at 7:10 PM
	Rezolute Inc RZLT morningstar.com - November 5 at 12:59 PM
	Rezolute Receives Priority Medicines (PRIME) Eligibility from European Medicines Agency for Enhanced Regulatory Support of RZ358 in Congenital Hyperinsulinism finance.yahoo.com - October 17 at 8:41 AM
	Rezolute Announces Further Evidence of RZ358's Efficacy in Tumor-Mediated Hyperinsulinism stockhouse.com - October 11 at 12:14 PM
	Rezolute Announces Further Evidence of RZ358’s Efficacy in Tumor-Mediated Hyperinsulinism finance.yahoo.com - October 11 at 12:14 PM
	Rezolute, Inc.'s (NASDAQ:RZLT) Intrinsic Value Is Potentially 71% Above Its Share Price finance.yahoo.com - October 2 at 8:32 AM
	Expert Ratings for Rezolute markets.businessinsider.com - September 18 at 1:53 PM
	Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT), TG Therapeutics (TGTX) and Harpoon Therapeutics (HARP) markets.businessinsider.com - September 18 at 8:52 AM
	Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Iovance Biotherapeutics (IOVA) markets.businessinsider.com - September 15 at 9:56 AM
	Rezolute Reports Full Year Fiscal 2023 Results and Highlights Company Progress finance.yahoo.com - September 14 at 6:27 PM

Get Rezolute News Delivered to You Automatically

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

RZLT Media Mentions By Week

RZLT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RZLT
News Sentiment
▼
1.00

0.49
▲
Average
Medical
News Sentiment

RZLT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RZLT Articles
This Week
▼
6

1
▲
RZLT Articles
Average Week

Get Rezolute News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:RZLT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Rezolute (RZLT) News Today

RZLT Media Mentions By Week

RZLT Media Sentiment

RZLT News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info